Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The Company's initial foc... Read more
MarketWatch
CNBC
CNBC
CNBC
Access detailed stock analysis from LSEG including analyst price target estimates.